GPT and Hepatic fibrosis: Despite a reduction in proportion with elevated alanine aminotransferase (ALT) (28.5% vs 19.8%, P = 0.01), a greater number of patients had indeterminate or high‐risk for liver fibrosis on NITs in CR‐2 (FIB‐4: 43.4% vs 31.8%, P < 0.01; NFS: 63.0% vs 53.5%, P = 0.02) (Table 3, Fig. 4).